The evolving role of CETP inhibition: beyond HDL cholesterol
File(s)Lancet Editorial V4.docx (21.47 KB)
Accepted version
Author(s)
Ray, KK
Vallejo-Vaz, AJ
Type
Journal Article
Date Issued
2015-08-01
Date Acceptance
2015-05-28
Citation
Lancet, 2015, 386 (9992), pp.412-414
ISSN
0140-6736
Publisher
Elsevier
Start Page
412
End Page
414
Journal / Book Title
Lancet
Volume
386
Issue
9992
Copyright Statement
Copyright © 2015 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358761700008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
ACUTE CORONARY SYNDROME
CARDIOVASCULAR EVENTS
LDL CHOLESTEROL
HIGH-RISK
DISEASE
LIPOPROTEIN
ANACETRAPIB
STATINS
LIPIDS
TRIAL
Publication Status
Published
Date Publish Online
2015-06-02